Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications

Fig. 1

Expression of CD160 by TNBC tumor cells. a Healthy (n = 3) or tumor (n = 3) tissue from TNBC patients was subjected to immunostaining using anti-CD160 mAb H3. Displayed images are from representative samples. b After adhesion on glass slides and fixation, TNBC cell lines were incubated with anti-CD160 mAb H3 followed by AlexaFluor594-coupled anti-mouse Igs antibodies. Slides were mounted with a Dapi-containing medium for nuclei counterstaining (blue). Images were acquired on a Nikon Ni fluorescence microscope. Magnification: 60×

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us